Atlas Trials

Clinical Characteristics of Patients With Anti-Collapsin Response Mediator Protein 2 Antibodies in Encephalitis or Encephalomyelitis

Clinical trial NCT07036042 · COMPLETED

Trial details

NCT number
NCT07036042
Sponsor
Nanfang Hospital, Southern Medical University
Status
COMPLETED
Study type
OBSERVATIONAL
Autoimmune Encephalitis
Start date
2022-06-01
Primary completion
2024-12-31
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.